Evidence map›Paper›PMID 42802127›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2026

[IOX1 alleviates hepatic ischemia-reperfusion injury by inhibiting mitogen-activated protein kinase signaling pathway].

S C Hu, Y G Lei, Y C Huang, H Q Liu, J Z Ge, K Ni, B Yang, X Xu

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S C HuThe Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Y G LeiZhejiang University School of Medicine, Hangzhou 310058, China.
Y C HuangThe Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.
H Q LiuDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
J Z GeDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
K NiDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
B YangDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
X XuHepatobiliary Center of The First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.

Funding

Key Research & Development +X Program of Zhejiang Province 2024C03051Major Research plan of the National Natural Science Foundation of China 92159202The Construction Fund of Key Medical Disciplines of Hangzhou OO20200093Young Program of National Natural Science Foundation of China 82302893Zhejiang Provincial Natural Science Foundation LQ24H160011
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LiverMAP Kinase Signaling SystemOxyquinolineReperfusion InjuryAnimalsApoptosisDisease Models, AnimalHepatocytesMaleMiceMice, Inbred C57BLOxidative StressReactive Oxygen SpeciesSignal TransductionOxyquinolineReactive Oxygen Species

Identifiers

PMID42802127
PMCPMC13616981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.